A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511405-27-00

Acronym

MK-1708-002

Enrollment

Registered

2024-04-29

Start date

2024-05-08

Completion date

2024-09-16

Last updated

2024-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic lateral sclerosis and Alzheimer’s disease

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026